Cases and


Webinar “Clinical trials in diabetes: approaches to drug development and methods for effectiveness and safety evaluating”

Currently diabetology is one of the most actively developing branches of medical science. Because there is high prevalence of diabetes among the world's population with serious problems and chronic complications. The development of new drugs for the treatment of diabetes needs in clinical trials. Studies in diabetology have a number of features, which we will discuss in our webinar.

What will we discuss in Webinar?

  • Peculiarity of clinical trials in diabetology

  • What to look for

  • Typical mistakes

For whom?

For drug developers, pharmaceutical and biotech companies, clinical trial sponsors and marketing authorization holders, participants of the clinical trial market, doctors.


Julia  Trakhtenberg, IPHARMA Medical Director